High contrast breast cancer biomarker imaging using upconverting nanoparticles

Research output: Contribution to journalArticlepeer-review

Abstract

Breast cancer is a leading cause of death in women and has scope for improvement in treatment stratification. We report the use of high contrast UCNP staining to distinguish different levels of HER2 expression in HER2 analyte control and HER2-positive breast cancer tissue biopsies. A contrast of 40 was found as compared to the negative control and 25 as compared to conventional DAB staining.

Original languageEnglish
Article numberJM1A.4
JournalOptics InfoBase Conference Papers
Publication statusPublished - 2022
EventClinical and Translational Biophotonics, Translational 2022 - Fort Lauderdale, United States
Duration: 24 Apr 202227 Apr 2022

Fingerprint

Dive into the research topics of 'High contrast breast cancer biomarker imaging using upconverting nanoparticles'. Together they form a unique fingerprint.

Cite this